CA1039191A - Melange antibacterien contenant un compose du type 3-fluoro-d-analine et de la cycloserine n-substituee - Google Patents

Melange antibacterien contenant un compose du type 3-fluoro-d-analine et de la cycloserine n-substituee

Info

Publication number
CA1039191A
CA1039191A CA205,968A CA205968A CA1039191A CA 1039191 A CA1039191 A CA 1039191A CA 205968 A CA205968 A CA 205968A CA 1039191 A CA1039191 A CA 1039191A
Authority
CA
Canada
Prior art keywords
fluoro
alanine
methyl
oxo
butenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA205,968A
Other languages
English (en)
Other versions
CA205968S (en
Inventor
Frederick M. Kahan
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of CA1039191A publication Critical patent/CA1039191A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA205,968A 1973-08-10 1974-07-30 Melange antibacterien contenant un compose du type 3-fluoro-d-analine et de la cycloserine n-substituee Expired CA1039191A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38757173A 1973-08-10 1973-08-10
US47879374A 1974-06-13 1974-06-13

Publications (1)

Publication Number Publication Date
CA1039191A true CA1039191A (fr) 1978-09-26

Family

ID=27011935

Family Applications (1)

Application Number Title Priority Date Filing Date
CA205,968A Expired CA1039191A (fr) 1973-08-10 1974-07-30 Melange antibacterien contenant un compose du type 3-fluoro-d-analine et de la cycloserine n-substituee

Country Status (11)

Country Link
CA (1) CA1039191A (fr)
CY (1) CY1054A (fr)
DE (1) DE2436959C2 (fr)
FR (1) FR2240000B2 (fr)
GB (1) GB1457950A (fr)
HK (1) HK23280A (fr)
IE (1) IE39587B1 (fr)
IL (1) IL45174A (fr)
KE (1) KE3042A (fr)
MY (1) MY8100050A (fr)
NL (1) NL181407C (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4034713A1 (de) * 1990-11-01 1992-05-07 Bayer Ag 3-oxy-substituierte isoxazoline, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung von endoparasiten
EP1143941A3 (fr) * 1999-01-13 2002-02-06 Jomaa Pharmaka GmbH Utilisation de 3-isoxazolidinones et d'hydroxylaminoacides pour le traitement d'infections

Also Published As

Publication number Publication date
NL181407C (nl) 1987-08-17
IL45174A (en) 1976-12-31
DE2436959A1 (de) 1975-02-20
IE39587B1 (en) 1978-11-08
FR2240000B2 (fr) 1977-10-28
NL7409574A (nl) 1975-02-12
HK23280A (en) 1980-05-09
MY8100050A (en) 1981-12-31
GB1457950A (en) 1976-12-08
AU7125074A (en) 1976-01-15
CY1054A (en) 1980-08-01
FR2240000A2 (fr) 1975-03-07
DE2436959C2 (de) 1987-03-05
IE39587L (en) 1975-02-10
KE3042A (en) 1980-05-09

Similar Documents

Publication Publication Date Title
CA2145078C (fr) Derives cristallin de penicilline, sa production et son utilisation
KR940005636A (ko) 트리아졸릴티오메틸티오 세팔로스포린 염산염, 그의 수화물 결정 및 이들의 제조방법
ES8302001A1 (es) Un procedimiento para la preparacion de nuevos derivados de cefalospirina.
US4455305A (en) Composition for the treatment of colitis ulcerosa, enteritis regionalis crohn (morbus crohn), chronic nonspecific colitis and diverticulitis and the use of salicylazobenzoic acid for the preparation of such compositions
KR890002166A (ko) 클라불라닉산 칼륨
CA1039191A (fr) Melange antibacterien contenant un compose du type 3-fluoro-d-analine et de la cycloserine n-substituee
US20040229825A1 (en) Pharmaceutical composition for treatment of infection with drug resistant bacterium and disinfectant
US4053609A (en) Penicillins and processes for preparing the same
US4031231A (en) Antibacterial composition comprising 3-fluoro-D-alanine or deutero analog in combination with auto-antagonist inhibitor
US3903285A (en) Method for treating parkinsonism
US4507239A (en) Penicillin derivatives and process for preparation
US2756226A (en) Acid-stable penicillins
PL81921B1 (fr)
US5142042A (en) Process for preparing well crystallized alkali metal salts of 3, 7-substituted 7-aminocephalosporanic acid derivatives
IE852522L (en) Compositions containing a penem or carbapenem antibiotic
US3862186A (en) Process for the production of cephalexin monohydrate
KR920006911B1 (ko) 안정한 피록시캄 주사액 조성물 및 그의 제조방법
US4001231A (en) Process for making a methenamine salt of an optically active acid
SU1015830A3 (ru) Способ получени сложных эфиров 6-амидинопенициллановых кислот или их аддитивных солей с кислотами и его вариант
BE818335R (fr) Composition antibacterienne et procede
DE3427865C2 (fr)
US3474089A (en) Substituted adamantyl penicillins
LU86678A1 (fr) Carbapenemes portant en position 2 un substituant heterothioalcoylthio quaternise
US8168622B2 (en) β-lactamase-resistant cephalosporin ester compounds and salts of thereof
US4205081A (en) Composition and method for preventing or treating swine dysentery